Approval from the state for Dana-Farber Cancer Institute to build a freestanding hospital in Longwood Medical Area means progress for the cancer institute’s plan, as well as potential expansion of ...

The U.S. Food and Drug Administration has approved cabozantinib (Cabometyx), an oral tyrosine kinase inhibitor, for patients ...

Determination of Need helps pave the way for the region's only dedicated cancer hospital, amid a multi-agency regulatory processThe Massachusetts ...

Dana-Farber got the OK from the Massachusetts Public Health Council to build a new cancer hospital​ in Boston.

The renovations at the state's biggest health system will help create the Mass General Brigham Cancer Institute.